Abstract
The central and peripheral actions of the endogenous neurotransmitter acetylcholine (ACh) are exerted at two main types of receptor, present in both the central and peripheral nervous system of all mammals. Their definition and pharmacological classification dates back to the work of Sir Henry Dale (1914), who demonstrated that certain actions of ACh on smooth muscle can be mimicked by muscarine while other actions of ACh on, for example, striated muscle can be mimicked by nicotine. The acetylcholine receptors at which muscarine is an agonist are termed muscarinic acetylcholine receptors (mAChRs). Dale also pointed out that the muscarinic actions of ACh can be blocked by atropine. Up to now the use of muscarine as agonist and of atropine as antagonist have provided the best definition of a muscarinic action in all contexts, physiological, pharmacological and biochemical.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akiyama K, Watson M, Roeske WR, Yamamura HI (1984) High-affinity [3H]pirenzepine binding to putative M i muscarinic sites in the neuroblastoma x glioma hybrid cell line (NG 108-15). Biochem Biophys Res Commun 119:289–297
Aquilonius SM (1978) Physostigmine in the treatment of drug overdose. In: Jenden DJ (ed) Cholinergic mechanisms and psychopharmacology. Plenum, New York, pp 817–825 (Advances in behavioral biology, vol 24)
Aronstam RS, Eldefrawi ME (1979) Transition and heavy metal inhibition of ligand binding to muscarinic acetylcholine receptors from rat brain. Toxicol Appl Pharmacol 48:489–496
Aronstam RS, Narayanan L (1981) 3-Chlorodibenzazepine binding to cholinergic receptors and ion channels. Res Commun Chem Pathol Pharmacol 34:551–554
Aronstam RS, Abood LG, MacNeil MK (1977) Muscarinic cholinergic binding in human erythrocyte membranes. Life Sci 20:1175–1180
Aronstam RS, Eldefrawi AT, Eldefrawi ME (1980) Similarities in the binding of muscarinic receptor and the ionic channel of the nicotinic receptor. Biochem Pharmacol 29:1311–1314
Avissar S, Moscona-Amir E, Sokolovsky M (1982) Photoaffinity labeling reveals two muscarinic receptor macromolecules associated with the presence of calcium in rat adenohypophysis. FEBS Lett 150:343–346
Babkin BP (1950) Secretary mechanisms of the digestive glands, 2nd edn. Hoeber, New York
Barchas JD, Berger PA, Ciaranello RD, Elliott GR (1977) Physopharmacology. Oxford University Press, New York
Bartfai R, Anner J, Schultzberg M, Montelius J (1974) Partial purification and characterization on the muscarinic acetylcholine receptor from rat cerebral cortex. Biophys Biochem Res Commun 59:725–733
Bartfai R, Study RF, Greengard P (1977) Muscarinic stimulation and cGMP synthesis. In: Jenden DE (ed) Cholinergic mechanisms and psychopharmacology. Plenum, New York, pp 285–295
Bartfai T, Breakefield XO, Greengard P (1978) Regulation of synthesis of guanosine 3´5´-cyclic monophosphate in neuroblastoma cells. Biochem J 176:119–127
Bartus RT, Dean RL III, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408–417
Baumgold J, Abood LG, Aronstam R (1977) Studies on the relationship of binding affinity to psychoactive and anticholinergic potency of a group of psychotomimetic glycolates. Brain Res 124:331–340
Becker CE, Tong TG, Boerner U, Roe RL, Scott RAT, MacQuarrie MB, Bartter F (1979) Diagnosis and treatment of Amanita phalloides type mushroom poisoning. West J Med 125:100–109
Beld AJ, Ariens EJ (1974) Stereospecific binding as a tool in attempts to localize and isolate muscarinic receptors. II. Binding of (+)benzetimide, (−)benzetimide and atropine to a fraction from bovine tracheae, smooth muscle and to bovine caudate nucleus. Eur J Pharmacol 25:203–209
Ben-Baruch G, Schreiber G, Sokolovsky M (1982) Cooperativity pattern in the interaction of the antiestrogen drug clomiphene with the muscarinic receptors. Mol Pharmacol 21:287–293
Berrie CP, Birdsall NJM, Burgen ASV, Hulme EC (1979) Guanine nucleotides modulate muscarinic receptor binding in the heart. Biochem Biophys Res Commun 87: 1000–1005
Berrie CP, Birdsall NJM, Hulme EC, Keen M, Stockton JM, Wheatley M (1986) Characteristics of two biochemical responses to stimulation of muscarinic cholinergic receptors. Trends Pharmacol Sci [Suppl]78:8–13
Birdsall NJM, Hulme EC (1983) Muscarinic receptor subclasses. Trends Pharmacol Sci 4:459–463
Birdsall NJM, Burgen ASV, Hulme EC (1978) The binding of agonists to brain muscarinic receptors. Mol Pharmacol 14:723–736
Birdsall NJM, Burgen ASV, Hulme EC (1980 a) The binding properties of muscarinic receptors in the brain of the frog (R. temporaria). Brain Res 184:385–393
Birdsall NJM, Hulme EC, Burgen A (1980 b) The character of muscarinic receptors in different regions of the rat brain. Proc R Soc Lond [Biol] 207 (1166):1–12
Birdsall NJM, Burgen ASV, Hulme EC, Wong EHF (1983 a) The effects of p-chloromer-curibenzoate on muscarinic receptors in the cerebral cortex. Br J Pharmacol 80:187–196
Birdsall NJM, Burgen ASV, Hulme EC, Wong EHF (1983 b) The effect of p-chloromer-curibenzoate on structure-binding relationships of muscarinic receptors in the rat cortex. Br J Pharmacol 80:197–204
Bohman B, Halaris A, Karbowski M (1981) Effects of tricyclic antidepressants on muscarinic cholinergic receptor binding in mouse brain. Life Sci 29:833–841
Brown DA, Adams PR (1982) Muscarinic suppression of a novel voltage-sensitive K+-current in a vertebrate neuron. Nature 283:673–676
Brown JH, Brown SL (1984) Agonists differentiate muscarinic receptors that inhibit cyclic AMP formation from those that stimulate phosphoinositide metabolism. J Biol Chem 259:3777–3781
Burgen ASV, Spero L (1968) The action of acetylcholine and other drugs on the efflux of potassium and rubidium from smooth muscle of guinea pig intestine. Br J Pharmacol 34:98–115
Burgen ASV, Hiley CR, Young JM (1974 a) The properties of muscarinic receptors in mammalian cerebral cortex. Br J Pharmacol 51:279–285
Burgen ASV, Hiley CR, Young JM (1974 b) Binding of 3H propyl benzilyl choline mustard by longitudinal muscle strips from guinea pig small intestine. Br J Pharmacol 50:145–151
Burn JH (1952) Practical pharmacology. Blackwell, Oxford
Bylund DB (1981) Interactions of neuroleptic metabolites with dopaminergic, alpha-adrenergic and muscarinic cholinergic receptors. J Pharmacol Exp Ther 217:81–86
Chakrabarti JK, Hotten TM, Morgan SE, Pullar IA, Rackham DM, Risius FC, Wedley S, Chaney MO, Jones ND (1982) Effects of conformationally restricted 4-piperazinyl-10H thienobenzodiazepine neuroleptics on central dopaminergic and cholinergic systems. J Med Chem 25:1133–1140
Chatelain P, Waelbroeck M, De Neef P, Robberecht P, Christophe J (1983) Increased number of high-affinity muscarinic receptors in rat heart after phenylhydrazine treatment. Eur J Pharmacol 91:279–282
Cheng Y-C, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108
Cohen-Armon M, Henis YI, Kloog Y, Sokolovsky M (1985) Interactions of quinidine and lidocaine with rat brain and heart muscarinic receptors. Biochem Biophys Res Commun 127:326–332
Costa LG, Schwab BW, Murphy SD (1982) Differential alterations of cholinergic muscarinic receptors during chronic and acute tolerance to organophosphorus insecticides. Biochem Pharmacol 32:3407–3413
Dale HH (1914) The action of certain esters and ethers of choline and their relation to muscarine. J Pharmacol 6:147–190
Danielsson E, Peterson L-L, Grundin R, Ögren S-O, Bartfai T (1985) Anticholinergic potency of psychoactive drugs in human and rat cerebral cortex and striatum. Life Sci 36:1451–1457
Danielsson E, Unden A, Nordstrom Ö, Ögren S-O, Bartfai T (1986) Interactions of alaproclate, a selective 5-HT-uptake blocker, with muscarinic receptors: in vivo and in vitro studies. In: Hanin J (ed) Dynamics and function of the cholinergic systems. Plenum, New York, pp 415–422
Danielsson E, Eckernäs S-Å, Westlind-Danielsson A, Nordstrom Ö, Bartfai T, Wallin A, Gottfries C-G (1988) VIP-sensitive adenylate cyclase, guanylate cyclase, muscarinic receptors, choline acetyltransferase and acetylcholinesterase, in brain tissue afflicted by Alzheimer’s disease/senile dementia of the Alzheimer type. Neurobiol Aging 9:153–162
Dixon RAF, Kobilka BK, Strader DJ, Benovik JL, Dohlman HG, Frielle R, Bolanowski MA, Bennett CD, Rands E, Diehl RE, Lefkowitz RJ, Strader CD (1986) Cloning of the gene and cDNA for mammalian β-receptors and homology with rhodopsin. Nature 321:75–79
Dudai Y (1980) Cholinergic receptors of Drosophila. In: Satelle DB (ed) Receptors, neurotransmitters, hormones, and pheromones of insects. Proc workshop, Cambridge, 1979. Elsevier, Amsterdam, pp 93–110
Dudai Y, Ben-Barak J (1977) Muscarinic receptor in Drosophila melanogaster demonstrated by binding of [3H]quinuclidinyl benzilate. FEBS Lett 81:134–136
Dudai Y, Yavin E (1978) Ontogenesis of muscarinic receptors and acetylcholinesterase in differentiating rat cerebral cells in culture. Brain Res 155:368–373
Ehlert FJ (1985) The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium. Mol Pharmacol 28:410–421
Ehlert FJ, Dumont Y, Roeske WR, Yamamura HI (1980 a) Muscarinic receptor binding in rat brain using the agonist [3H]cis-methyldioxolane. Life Sci 26:961–967
Ehlert FJ, Roeske WR, Yamamura HI (1980 b) Regulation of muscarinic receptor binding by guanine nucleotides and N-ethylmaleimide. J Supramol Struct 14:149–162
El-Fakahany E, Richelson E (1983) Antagonism by antidepressants of mAChR of human brain. Br J Pharmacol 78:97–102
Ellis J, Hoss W (1980) Analysis of regional variations in the variations in the affinities of muscarinic agonists in the rat brain. Brain Res 193:189–198
Emmelin N (1967) Nervous control of salivary glands. In: Lode CF (ed) The handbook of physiology, sect 6, vol 2. American Physiological Society, Washington, pp 595–635
Engström C, Unden A, Ladinsky H, Consolo S, Bartfai T (1986) BM-5, a centrally active partial muscarinic agonist with low tremorogenic activity. In vivo and in vitro studies. Psychopharmacology (in press)
Enna SJ, Bird ED, Bennett JP, Bylund DB, Yamamura HI, Iversen LL, Snyder SH (1976) Huntington’s chorea. Changes in neurotransmitter receptors in the brain. N Engl J Med 294:1305–1309
Fairhurst SD, Whittaker ML, Ehlert FJ (1980) Interactions of D600 (methoxyverapamil) and located anesthetics with rat brain -adrenergic and muscarinic receptors. Biochem Pharmacol 29:155–162
Farrar J, Hoss W (1984) Effects of copper on the binding of agonists and antagonists to muscarinic receptors in rat brain. Biochem Pharmacol 33:2849–2856
Fjalland B, Christensen AV, Hyttel J (1977) Peripheral and cental muscarinic receptor affinity of psychotropic drugs. Naunyn Schmiedebergs Arch Pharmacol 301:5–9
Gabrielewitz A, Kloog Y, Kalir A, Balderman D, Sokolovsky M (1980) Interaction of phecyclidine and its new adamantyl derivatives with muscarinic receptors. Life Sci 26:89–95
George W, Poison JB, O’Toole AG, Goldberg ND (1970) Elevation of guanosine 3´5´-cyclic phosphate in rat heart after perfusion with acetylcholine. Proc Natl Acad Sci USA 66:398–403
Gibson RE, Rzeszotarski WJ, Jagoda EM, Francis BE, Reba RC, Eckelman WC (1984) [125I]3-quinuclidinyl-4-iodobenzilate: a high affinity high specific activity radioligand for the M1 and M2 acetylcholine receptors. Life Sci 34:2287–2296
Goldberg ND, Haddox MK (1977) Cyclic GMP metabolism and involvement in biological regulation. Annu Rev Biochem 46:823–896
Goldman ME, Erickson CK (1983) Effects of acute and chronic administration of antidepressant drugs on the central cholinergic nervous system. Comparison with anticholinergic drugs. Neuropharmacology 22:1215–1222
Golds PR, Przyslo FR, Strange PG (1980) The binding of some antidepressant drugs to brain muscarinic acetylcholine receptors. Br J Pharmacol 68:541–549
Gorissen H, Aerts G, Laduron P (1978) Characterization of digitonin-solubilized muscarinic receptor from rat brain. FEBS Lett 96:64–68
Gossuin A, Maloteaux JM, Trouet A, Laduron P (1984) Differentiation between ligand trapping into intact cells and binding on muscarinic receptors. Biochem Biophys Acta 804:100–106
Goyal RK, Rattan S (1978) Neurohormonal, hormonal and drug receptors for the lower esophagal spincter. Gastroenterology 74:598–619
Grammas P, Diglio AA, Marks BH, Giacomelli F, Wiener J (1983) Identification of muscarinic receptor in rat cerebral cortial microvessels. J Neurochem 40:645–651
Gurwitz D, Sokolovsky M (1980) Agonist-specific regulation of muscarinic receptors by transition metal ions and guanine nucleotides. Biochem Biophys Res Commun 94:1296–1304
Gurwitz D, Baron B, Sokolovsky M (1984 a) Copper ions and diamide induce a high affinity guanine-nucleotide-insensitive state for muscarinic agonists. Biochem Biophys Res Commun 120:271–277
Gurwitz D, Razon N, Sokolovsky M, Soreq H (1984 b) Expression of muscarinic binding sites in primary human brain tumors. Dev Brain Res 14:61–70
Gurwitz D, Kloog Y, Sokolovsky M (1984 c) Recognition of the muscarinic receptor by its endogenous neurotransmitter: binding of [3H]acetylcholine and its modulation by transition metal ions and guanine nucleotides. Proc Natl Acad Sci USA 81:3650–3654
Haga K, Haga T (1983) Affinity chromatography of the muscarinic acetylcholine receptor. J Biol Chem 258:13575–13578
Haga K, Haga T (1985) Purification of the muscarinic acetylcholine receptor from porcine brain. J Biol Chem 260:7927–7935
Haga K, Haga T, Ichiyama A, Katada T, Kurose H, Ui M (1985) Functional reconstitution of purified muscarinic receptors and inhibitory guanine nucleotide regulatory protein. Nature 316:731–733
Hammer R, Giachetti A (1982) Muscarinic receptor subtype: M1 and M2; biochemical and functional characterization. Life Sci 31:2991–2998
Hammer R, Berrie CP, Birdsall NJM, Burgen ASV, Hulme EC (1980) Pirenzepine distinguishes between different subclasses of muscarinic receptors. Nature 283:90–92
Hartzell HC (1981) Mechanisms of slow postsynaptic potentials. Nature 291:539–544
Hedlund B, Bartfai R (1981) Binding of 3H-pilocarpine to membranes from rat cerebral cortex. Naunyn Schmiedebergs Arch Pharmacol 317:126–130
Hedlund B, Shepherd GM (1983) Biochemical studies on muscarinic receptors in the salamander olfactory epithelium. FEBS Lett 162:428–431
Hedlund B, Gamarra M, Bartfai T (1979) Inhibition of striatal muscarinic receptors in vivo by cadmium. Brain Res 168:216–218
Heiser JF, Gillin JC (1971) The reversal of anticholinergic drug induced delirium and coma with physostigmine. Am J Psychiatry 127:1050–1052
Hokin MR, Hokin LE (1952) Enzyme secretion and the incorporation of P32 into phospholipides of pancreas slices. J Biol Chem 203:967–977
Hulme EC, Burgen ASV, Birdsall NJM (1976) Interactions of agonist and antagonist with the muscarinic receptor. In: Smooth muscle pharmacology and physiology. INSERM 50:49–70
Hulme EC, Birdsall NJM, Burgen ASV, Mehta P (1978) The binding of antagonists to brain muscarinic receptors. Mol Pharmacol 14:737–750
Hulme EC, Berrie CP, Haga T, Birdsall NJM, Burgen ASV, Stockton J (1983) Solubilization and molecular characterization of muscarinic acetylcholine receptors. J Recept Res 3:301–311
Hurko O (1978) Specific [3H]-quinuclidinyl benzilate binding activity in digitonin-solubilized preparations from bovine brain. Arch Biochem Biophys 190:434–445
Hyslop DK, Taylor DP (1980) The interaction of trazodone with rat brain muscarinic cholinoreceptors. Br J Pharmacol 71:359–361
Jacobson MD, Wusterman M, Downes CP (1985) Muscarinic receptors and hydrolysis of inositol phospholipids in rat cerebral cortex and parotial gland. J Neurochem 44:465–472
Järv J, Bartfai T (1982) Importance of hydrophobic interactions in the antagonist binding to the muscarinic acetylcholine receptor. Acta Chem Scand [B] 36:487–490
Järv J, Hedlund B, Bartfai T (1979) Kinetic studies on muscarinic antagonist-agonist competition. J Biol Chem 255:2649–2651
Jenden DJ (1965) Studies on tremorine antagonism by structurally related compounds. In: Costa E, Cote LJ, Yaln MD (eds) Biochemistry and pharmacology of the basal ganglia. Raven, New York, pp 159–170
Kato G, Carson S, Kemel ML, Glowinski J, Giorguieff MF (1978) Changes in striatal specific 3-H-atropine binding after unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurones. Life Sci 22:1607–1614
Kilbinger H, Wagner B (1979) The role of presynaptic receptors in regulating acetylcholine release from peripheral cholinergic neurons. In: Langer SH, Starke K, Dubocowich ML (eds) Presynaptic receptors. Pergamon, Oxford, pp 347–351
Klein WL, Nathanson N, Nirenberg M (1979) Muscarinic acetylcholine receptor regulation by accelerated rate of receptor loss. Biochim Biophys Res Commun 90:506–512
Kloog Y, Sokolovsky M (1978) Studies on muscarinic AChR from mouse brain: characterization of the interaction with antagonists. Brain Res 144:31–48
Kloog Y, Michaelson DM, Sokolovsky M (1978) Identification of muscarinic receptors in the Torpedo electric organ. Evidence for their presynaptic localization. FEBS Lett 95:331–334
Kloog Y, Egozi Y, Sokolovsky M (1979) Characterization of muscarinic acetylcholine receptors from mouse brain: evidence for regional heterogenity and isomerization. Mol Pharmacol 15:545–558
Kubo T, Fukuda K, Mikami A, Maeda A, Takahashi H, Mishina M, Haga T, Haga K, Ichiyama A, Kangawa K, Kojima M, Matsuo H, Hirose T, Numa S (1986) Cloning, sequencing and expression of complementary DNA encoding the muscarinic acetylcholine receptor. Nature 323:411–416
Kuhar MJ, Birdsall NJM, Burgen ASV, Hulme EC (1980) Ontogeny of muscarinic receptors in rat brain. Brain Res 184:375–383
Kurose H, Ui M (1985) Dual pathways of receptor-mediated cyclic GMP generation in NG 108-15 cells as differentiated by susceptibility of islet-activating protein, pertussis toxin. Arch Biochem Biophys 238:424–434
Laduron P (1980) Dopamine and muscarinic receptors in vivo identification, axonal transport and solubilization. In: Yamamura HI, Olsen U (eds) Psychopharmacology and biochemistry of neurotransmitter receptors. Elsevier North-Holland, Amsterdam, pp 115–132
Laduron PM, Leysen JE (1978) Is the low incidence of extrapyramidal side-effects of anti-psychotics associated with antimuscarinic properties? J Pharm Pharmacol 30:120–122
Laduron PM, Verwimp M, Leysen JE (1979) Stereospecific in vitro binding of [3H]dex- etimide to brain muscarinic receptors. J Neurochem 32:421–427
Lang W, Henke H (1983) Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients. Brain Res 267:271–280
Leslie EBA, Putney JW Jr, Sherman JM (1976) Adrenergic, β-adrenergic and cholinergic mechanisms for amylase secretion by rat parotid gland in vitro. J Physiol (Lond) 260:351–370
Levine RR, Birdsall NJM, Giachetti A, Hammer R, Iversen LL, Jenden DJ, North RA (eds) (1986) Subtypes of muscarinic receptors II. Trends Pharmacol Sci [Suppl] 78
Lopker A, Abood LG, Hoss W, Lionetti FJ (1980) Stereoselective muscarinic acetylcholine and opiate receptors in human phagocytic leucocytes. Biochem Pharmacol 29:1361–1365
Lundberg JM, Hedlund B, Bartfai T (1982) Vasoactive intestinal polypeptide enhances muscarinic ligand binding in cat submandibular salivary gland. Nature 295:147–149
Luthin GR, Wolfe BB (1984) Comparison of [3H]pirenzepine and [3H]quinuclidinylben-zilate binding to muscarinic cholinergic receptors in rat brain. J Pharmacol Exp Ther 228:648–655
Maayani S, Egazi Y, Pinchasi J, Sokolovsky M (1977) On the interactions of drugs with the cholinergic nervous system - IV. Biochem Pharmacol 26:1681–1687
Mantione CR, Hanin I (1980) Further characterization of human red blood cell membrane cholinergic receptors. Mol Pharmacol 18:28–32
McCormick DA, Prince DA (1986) Pirenzepine discriminates among ionic responses to acetylcholine in guinea-pig cerebral cortex and reticular nucleus of thalamus. Trends Pharmacol Sci [Suppl] 7:72–77
Meeker RB, Hardent TK (1982) Muscarinic cholinergic receptor-mediated activation of phosphodiesterase. Mol Pharmacol 22:310–319
Michell RH (1975) Inositol phospholipids and cell surface receptor function. Biochim Biophys Acta 415:81–147
Miller R, Hiley R (1975) Antimuscarinic actions of neuroleptic drugs. Adv Neurol 9:141–154
Milligan G, Strange PG (1984) Muscarinic acetylcholine receptors in neuroblastoma cells: lack of effect of veratrum alkaloids on receptor number. J Neurochem 43:33–41
Nathanson NM (1983) Binding of agonists and antagonists to muscarinic acetylcholine receptor on intact cultured heart cells. J Neurochem 41:1545–1549
Nathanson NM, Klein WL, Nirenberg M (1978) Regulation of adenylate cyclase activity mediated by muscarinic acetylcholine receptors. Proc Natl Acad Sci USA 75: 1788–1791
Nilvebrant L, Sparf B (1982) Muscarinic receptor binding in the parotid gland. Different affinities of some anticholinergic drugs between the parotid pland and ileum. Scand J Gastroenterol [Suppl 72] 17:69–76
Nordstrom Ö, Bartfai T (1980) Muscarinic autoreceptor regulates acetylcholine release in rat hippocampus: in vitro evidence. Acta Physiol Scand 108:347–354
Nordstrom Ö, Westlind A, Unden A, Meyerson B, Sachs C, Bartfai T (1982) Pre- and postsynaptic muscarinic receptors in surgical samples from human cerebral cortex. Brain Res 234:287–297
North RA (1986) Muscarinic receptors and membrane ion conductances. Trends Pharmacol Sci [Suppl] 7:19–22
Nukina I (1983) Characteristics of muscarinic acetylcholine receptors in rat brain. Acta Med Okayama 37:179–191
Ögren S-O, Carlsson S, Bartfai T (1985) Serotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouse. Psychopharmacology 86:258–264
Onali P, Olianas MC, Schwatz JP, Costa P (1984) Molecular mechanisms involved in the inhibitory coupling of striatal muscarinic receptors to adenylate cyclase. Adv Biosci 48:163–174
Ovchinnikov Y (1982) Rhodopsin and bacriorhodopsins structure, function, relationships. FEBS Lett 148:179–191
Palacios JM, Kuhar MJ (1979) Choline: binding studies provide some evidence for a weak, direct agonist action in brain. Mol Pharmacol 16:1084–1088
Polak RL, Meeuws MM (1966) The influence of atropine on the release and uptake of acetylcholine by the isolated cerebral cortex of the rat. Biochem Pharmacol 15:989–992
Putney JW, Parod RJ (1978) Calcium-mediated effects of carbachol on cation pumping and sodium uptake in rat parotid gland. J Pharmacol Exp Ther 205:449–458
Raaijmakers JAM, Terpstra GK, van Rozen AJ, Witter A, Kreukniet J (1983) Muscarinic cholinergic receptors in peripheral lung tissue of normal subjects and of patients with chronic obstructive lung disease. Clin Sci 66:585–590
Rehavi M, Maayani S, Goldstein L, Assael M, Sokolovsky M (1977 a) Antimuscarinic properties of antidepressants: dibenzepin (Noveril). Psychopharmacology 54:35–38
Rehavi M, Maayani S, Sokolovsky M (1977 b) Tricyclic antidepressants as anti-muscarinic drugs: In vivo and in vitro studies. Biochem Pharmacol 26:1559–1567
Rehavi M, Maayani S, Sokolovsky M (1977 c) Enzymatic resolution and cholinergic properties of ± 3-quinuclidinol derivates. Life Sci 21:1293–1302
Rehavi M, Ramat O, Yavetz B, Sokolovsky M (1980) Amitryptiline: long-term treatment elevates alpha-adrenergic and muscarinic receptor binding in mouse brain. Brain Res 194:443–453
Repke H (1982) Regulatory process at the muscarinic acetylcholine receptor — an approach to a receptor model. Wiss Z Humboldt Univ Berlin Math Naturwiss Reihe 31:525–527
Richelson E, Divinetz-Romero S (1977) Blockade by psychotropic drugs of the muscarinic acetylcholine receptor in cultured nerve cells. Biol Psych 12:771–785
Ringdahl B (1984) Structural requirements for muscarinic receptor occupation and receptor activation by oxotremorine and analogs in the guinea pig ileum. Pharmacol Exp Ther 232:67–73
Ringdahl B, Ehler FJ, Jenden DJ (1982) Muscarinic activity and receptor binding of the enantiomers of acelidine and its methiodide. Mol Pharmacol 21:594–599
Robberecht P, Winaud J, Chatelain P, Poloczek P, Camus J-C, DeNeef P, Christophe JP (1981) Comparison of beta-adrenergic receptors and adenylate cyclase system with muscarinic receptors and guanylate cyclase activities in heart of spontaneously hypertensive rats. Biochem Pharmacol 30:385–387
Rodbell M (1980) The role of hormone receptors and GTP-regulatory proteins in membrane transduction. Nature 284:17–22
Rosenberger LB, Roeske WR, Yamamura HI (1979) The regulation of muscarinic receptor binding. J Biol Chem 255:820–823
Rotter A, Birdsall NJM, Burgen ASV, Field PM, Hulme EC, Raisman G (1979) Muscarinic receptors in the central nervous system of the rat. I. Technique for autoradiographic localization of the binding of [3H]-propylbenzilylcholine mustard and its distribution in the forebrain. Brain Res 1:141–165
Rumack BH (1973) Anticholinergic poisoning: treatment with physostigmine. Pediatrics 52:449–451
Schreiber G, Sokolovsky M (1985) Muscarinic receptor heterogeneity revealed by interaction with bretylium tosylate. Different ligand-receptor conformations versus different receptor subclasses. Mol Pharmacol 27:27–31
Schreiber G, Friedeman M, Sokolovsky M (1984) Interactions of bretylium tosylate with rat cardiac muscarinic receptors: possible pharmacological relevance to antiarrhythmic action. Circ Res 55:653–659
Schreiber G, Barak A, Sokolovsky M (1985) Disopyramide and quinidine bind with inverse selectivity to muscarinic receptors in cardiac and extracardiac rat tissues. J Cardiovasc Pharmacol 7:390–393
Smith CP, Huger FP (1983) Effect of zinc on [3H]QNB displacement by cholinergic agonists and antagonists. Biochem Pharmacol 32:377–380
Synder S, Greenberg D, Yamamura HJ (1974) Antischizophrenic drugs and brain cholinergic receptors: affinity for muscarinic sites predicts extrapyramidal effects. Arch Gen Psychiatry 31:58–61
Snyder SH, Yamamura HJ (1977) Antidepressants and the muscarinic acetylcholine receptor. Arch Gen Psychiatry 34:236–239
Sokolovsky M (1984) Muscarinic receptors. Int Rev Neurobiol 25:139–183
Sokolovsky M, Gurwitz D, Galron R (1980) Muscarinic receptor binding in mouse brain: regulation by guanine nucleotides. Biochem Biophys Res Commun 94:487–492
Sokolovsky M, Gurwitz D, Kloog Y (1983) Biochemical characterization of the muscarinic receptors. Adv Enzymol 137–196
Speth RC, Yamamura HI (1979) On the ability of choline and its analogues to interact with muscarinic cholinergic receptors in the rat brain. Eur J Pharmacol 58:197–201
Strange PG, Birdsall NJM, Burgen ASV (1978) Ligand-binding properties of the muscarinic acetylcholine receptor in mouse neuroblastoma cells. Biochem J 72:495–501
Szerb JC (1964) The effect of tertiary and quaternary atropine on cortical acetylcholine output and on the electroencephalogram in cats. Can J Physiol Pharmacol 42:303–314
Taylor P (1980) Cholinergic agonists. In: Goodman, Gilman (eds) The pharmacological basis of therapeutics. Macmillan, New York, pp 91–99
Tinkelberg JR, Berger PA (1977) Treatment of abusers of nonadditive drugs in psychopharmacology. In: Barchas JD et al. (eds) Oxford University Press, New York, pp 386–402
Tjörnhammar M-L, Bartfai T (1984) Interaction of drugs with the cyclic nucleotide generating enzymes in the central nervous system. Med Res Rev 3:513–534
Tollefson GD, Senogles SE (1983) A comparison of first and second generation antidepressants at the human muscarinic cholinergic receptor. J Clin Psychopharmacol 3:231–234
Tollefson GD, Senogles SE, Frey WH II, Tuason VB, Nicol SE (1982) A comparison of peripheral and central muscarinic cholinergic receptor affinities for psychotropic drugs. Biol Psychiatry 17:555–567
Uchida S, Takeyasu K, Matsuda T, Yoshida H (1979) Changes in muscarinic acetylcholine receptors of mice by chronic administrations of diisopropylfluorophosphate and papaverine. Life Sci 24:1805–1812
Vauquelin G, Andre C, De Backer J-P, Laduron P, Strosberg AD (1982) Agonist-mediated conformational changes of muscarinic receptors in rat brain. Eur J Biochem 125:117–124
Venter CJ, Fraser CM, Lindström J (1984) Monoclonal and anti-idiotypic antibodies. Probes for receptor structure and function. In: Venter CJ, Harrison L (eds) Receptor biochemistry and methodology, vol 4. Liss, New York, pp 117–140
Vincent JP, Cavey D, Kamenka JM, Geneste P, Lazdunski M (1978) Interaction of phencyclidines with the muscarinic and opiate receptors in the central nervous system. Brain Res 152:176–182
Wamsley JK, Gehlert DR, Roeske WR, Yamamura HI (1984) Muscarinic antagonist binding site heterogeneity as evidenced by autoradiography after direct labeling with [3H]- QNB and [3H]-pirenzepine. Life Sci 34:139–1402
Ward D, Trevor A (1981) Phenylcyclidine-induced alteration in rat muscarinic cholinergic receptor regulation. Eur J Pharmacol 74:189–193
Wastek GJ, Yamamura HI (1978) Biochemical characterization of the muscarinic cholinergic receptor in human brain: alterations in Huntington’s disease. Mol Pharmacol 14:768–780
Watson M, Roeske WR, Yamamura HI (1982) [3H]pirenzepine selectively identifies a high affinity population of muscarinic cholinergic receptors in the rat cerebral cortex. Life Sci 31:2019–2023
Watson M, Roeske W, Johnson PC, Yamamura HI (1984) [3H]pirenzepine identifies putative M1 muscarinic receptors in human stellate ganglia. Brain Res 290:179–182
Watson M, Roeske WR, Vickroy TW, Smith TL, Akiyama K, Gulya K, Duckies SP, Serra M, Adem A, Nordberg A, Gehlert DR, Wamsley JK, Yamamura HI (1986) Mapping of subtypes of muscarinic receptors in the human brain with receptor autoradiographic techniques. Trends Pharmacol Sci [Suppl] 7:46–55
Weinstein H, Maayani S, Pazhenchevsky B (1983) Multiple actions of phencyclidine: discriminant structure-activity relationship from molecular conformations and assay conditions. Fed Proc 42:2574–2578
Westlind A, Grynfarb M, Hedlund B, Bartfai T, Fuxe K (1981) Muscarinic supersensitivity induced by septal lesion or chronic atropine treatment. Brain Res 225:131–141
Wise BC, Shoji M, Kuo J, Fazi T (1980) Decrease or increase in cardiac muscarinic cholinergic receptor number in rats treated with methacholine or atropine. Biochem Biophys Res Commun 92:1136–1142
Wood PL, Etienne P, Lai S, Nair NPV, Finlayson MH, Gauthier S, Palo J, Haltia M, Paetau A, Bird ED (1983) A post-mortem comparison of the cortical cholinergic system in Alzheimer’s disease and Pick’s disease. J Neurol Sci 62:211–217
Wurtman RJ, Corkin SH, Crowclen (eds) (1983) Alzheimer’s disease: advances in basic research and therapeutics. Proceedings of the 3rd Meeting of the International Study Group on the Treatment of Memory Disorders with Ageing, Zürich
Yamamura HI, Snyder SH (1974 a) Muscarinic cholinergic binding in rat brain. Proc Natl Acad Sci USA 71:1725–1729
Yamamura HI, Snyder SH (1974 b) Muscarinic cholinergic receptor binding in the longitudinal muscle of the guinea pig ileum with [3H]quinuclidinyl benzilate. Mol Pharmacol 10:861–867
Yavin E, Harel S (1979) Muscarinic binding sites in the developing rabbit brain: regional distribution and ontogenesis in the prenatal and early neonatal cerebellum. FEBS Lett 97:151–154
Zalcman SJ, Neckers LM, Kaayalp O, Wyatt RJ (1981) Muscarinic cholinergic binding sites on intact human lymphocytes. Life Sci 29:69–73
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Järv, J., Bartfai, T. (1988). Muscarinic Acetylcholine Receptors. In: Whittaker, V.P. (eds) The Cholinergic Synapse. Handbook of Experimental Pharmacology, vol 86. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73220-1_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-73220-1_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-73222-5
Online ISBN: 978-3-642-73220-1
eBook Packages: Springer Book Archive